Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: An open label study

Akkaya, CENGİZ; Sivrioglu, Enver; Akgoz, Semra; Eker, SALİH; Kirli, Selcuk

doi:10.1002/hup.770

Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: An open label study

Atıf İçin Kopyala

Akkaya C., Sivrioglu E. Y., Akgoz S., Eker S. S., Kirli S.

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, cilt.21, sa.5, ss.337-345, 2006 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 21 Sayı: 5
Basım Tarihi: 2006
Doi Numarası: 10.1002/hup.770
Dergi Adı: HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.337-345
Anahtar Kelimeler: venlafaxine, reboxetine, depression, anxiety, depression with anxiety features, treatment, DOUBLE-BLIND, FLUOXETINE, RELAPSE, NORADRENALINE, COMORBIDITY, ASSOCIATION, PREDICTORS, MANAGEMENT, DISORDERS, LIFETIME
Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Objective The aim of this study was to compare the efficacy and tolerability of reboxetine in the treatment of major depressive disorder (MDD) and MDD with anxiety features to venlafaxine XR.